HCID 11568520, Verbindung → HCID 178511292, Verbindung

HRID 422635Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 422635
[N:1]([CH2:4][CH:5]1[CH2:8][CH:7]([C:9]2[N:13]3[CH:14]=[CH:15][N:16]=[C:17]([NH2:18])[C:12]3=[C:11]([C:19]3[CH:28]=[C:27]4[C:22]([CH:23]=[CH:24][C:25]([C:29]5[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=5)=[N:26]4)=[CH:21][CH:20]=3)[N:10]=2)[CH2:6]1)=[N+]=[N-]>C(O)C.[Pd].CC([O-])=O.CC([O-])=O.[Pb+2]>[NH2:1][CH2:4][C@@H:5]1[CH2:6][C@H:7]([C:9]2[N:13]3[CH:14]=[CH:15][N:16]=[C:17]([NH2:18])[C:12]3=[C:11]([C:19]3[CH:28]=[C:27]4[C:22]([CH:23]=[CH:24][C:25]([C:29]5[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=5)=[N:26]4)=[CH:21][CH:20]=3)[N:10]=2)[CH2:8]1

Komponenten

4

Edukt 1

HCID 11568520HCID 11568520, Verbindung

Produkt 1

HCID 178511292HCID 178511292, Verbindung

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 131709914Lindlars catalystKatalysatorHCID 702EthanolLösungsmittel

Versuchsvorschrift

3-[3-(Azidomethyl)cyclobutyl]-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-8-amine (0.81 mmol, 360 mg) was dissolved in hot ethanol (15 mL) and charged with Lindlar catalyst (0.14 mmol, 362 mg). The reaction mixture was purged with N2, evacuated and filled with H2. The reaction mixture was stirred under H2 for 16 h. The suspension was filtered through celite and the solvent was removed under reduced pressure. Part of the crude material (200 mg out of 300 mg) was purified by silica gel flush chromatography (Jones Flashmaster, 5 g/70 mL cartridge) eluting with 3% MeOH (7 N NH3) in DCM. The final compound was recrystalized from EtOAc and hexane to generate the desired product as a light yellow solid; 1H NMR (400 MHz, CDCl3) δ 8.42-8.41 (m, 1H), 8.27 (dd, J=8.0 Hz, 0.4 Hz, 1H), 8.21-8.19 (m, 2H), 7.95-7.92 (m, 3H), 7.57-7.48 (m, 3H), 7.19 (d, J=4.0 Hz, 1H), 7.11 (d, J=4.0 Hz, 1H), 5.20 (b, 2H), 3.73-3.69 (m, 1H), 2.81 (d, J=7.2 Hz, 2H), 2.66-2.62 (m, 2H), 2.58-2.48 (m, 1H), 2.36-2.30 (m, 2H); MS (ES+): m/z 421.13 (40) [MH+]; HPLC: tR=1.69 min (OpenLynx, polar—5 min).

Aufarbeitung

  1. customThe reaction mixture was purged with N2
  2. customevacuated
  3. additionfilled with H2
  4. filtrationThe suspension was filtered through celite
  5. customthe solvent was removed under reduced pressure
  6. customPart of the crude material (200 mg out of 300 mg) was purified by silica gel
  7. customflush chromatography (Jones Flashmaster, 5 g/70 mL cartridge)
  8. washeluting with 3% MeOH (7 N NH3) in DCM
  9. customThe final compound was recrystalized from EtOAc and hexane
  10. customHPLC: tR=1.69 min (OpenLynx, polar—5 min)

Quellen und Nachweise

ORD-Eintrag
ord-7f31a20e33b84443b79778f06ab7dee1
Quelldatensatz
uspto-grants-2012_01
Patentnummer
US08101613B2

Notizen zur Reaktion

Wird geladen…